Group President, APAC · ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Sang Yi

A named executive officer of ZIMMER BIOMET in every fiscal year CompBrief holds from FY2016 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$3,154,355

Salary $688,969Stock awards $1,750,095

FY2023: $3,384,994

4th of 5 named executive officers at Zimmer Biomet by FY2024 total.

5 named officers on file for ZIMMER BIOMET, FY2024

Sang Yi’s pay file — $29

  • 9 fiscal years of pay, line by line
  • 20 equity grants, each cited to its filing
  • ZBH’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ZIMMER BIOMET’s whole pay program stands against its peers

  • ZIMMER BIOMET’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ZBH→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 14, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Sang Yi’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Sang Yi compensation by year

ZIMMER BIOMET Summary Compensation Table · all 9 fiscal years held
In US dollars, as ZIMMER BIOMET reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Salary$459,156$480,372$512,478$549,920$658,333$623,307$638,853$609,950$688,969
Bonus$0$0$0$0$0—$0$0$0
Stock awards$500,040$549,994$1,400,353$749,968$800,410$1,075,000$1,361,788$2,000,273$1,750,095
Option awards$499,991$550,108$1,200,148$750,052$799,950$1,075,010$851,046$0$0
Non-equity incentive$505,178$572,683$474,759$592,814$446,081$478,802$595,104$633,166$571,018
Pension and deferred compensation$0$0$0$0$0$0$0$0$0
All other$143,871$69,674$72,401$71,559$116,270$120,761$124,048$141,605$144,273
Total$2,108,236$2,222,831$3,660,139$2,714,313$2,821,044$3,372,880$3,570,839$3,384,994$3,154,355

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ZIMMER BIOMET HOLDINGS, INC. DEF 14A filed April 14, 2025, accession 0000950170-25-053494, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ZIMMER BIOMET HOLDINGS, INC. filed document, accession 0000950170-25-053494. Every figure is read from that document and cited to the page and table it appears in. Filed April 14, 2025.

$2.1M
$2.2M
$3.7M
$2.7M
$2.8M
$3.4M
$3.6M
$3.4M
$3.2M
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU7,147$754,938—
PSU6,656$703,073—
RSU4,729$499,524—
PSU3,439$363,262—
PSU2,199$232,280—

Per the Outstanding Equity Awards at Fiscal Year-End table in ZIMMER BIOMET HOLDINGS, INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

16 Form 4 lines since the FY2024 proxy (filed April 14, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-05-29Sale—800$82.6627,251
2026-05-29Sale—4,200$82.6428,051
2026-03-06Exercise or conversion—2,364$0.0032,251
2026-03-06Exercise or conversion derivative—7,050$0.000
2026-03-06Exercise or conversion derivative—2,364$0.000
2026-03-06Exercise or conversion—7,050$0.0029,887
2026-02-25Exercise or conversion—2,785$0.0022,837
2026-02-25Exercise or conversion derivative—2,785$0.005,567

The 8 most recent of 16 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments ZIMMER BIOMET discloses, by trigger · FY2024
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Death$0$499,524$0$1,070,542
Voluntary resignation$0$0$0$0
Change in control and resignation for good reason$1,396,000$3,700,641$164,807$6,961,648
Retirement$0$0$0$0
Involuntary for cause$0$0$0$0
Involuntary termination without cause$698,000$0$0—
Change in control and involuntary termination$1,396,000$3,700,641$164,807—
Disability$0$0$0$571,018

Per the Potential Payments Upon Termination or Change in Control table in ZIMMER BIOMET HOLDINGS, INC.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.

ZIMMER BIOMET’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Ivan TornosPresident and CEO$14,992,868
Suketu UpadhyayCFO and EVP - Finance, Operations and Supply Chain$5,879,562
Wilfred van ZuilenGroup President, EMEA$3,483,831
Sang Yi · this pageGroup President, APAC$3,154,355
Mark BezjakPresident, Americas$3,046,574

The full ZIMMER BIOMET compensation record

free company brief

This page is one person within ZIMMER BIOMET's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ZIMMER BIOMET proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ZIMMER BIOMET's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sang Yi's compensation dossier · One-time report. No refunds.